Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00029289 |
Date of registration:
|
09/01/2002 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effects of Lutein in Retinitis Pigmentosa
|
Scientific title:
|
Effects of Lutein in Retinitis Pigmentosa |
Date of first enrolment:
|
April 2001 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00029289 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
Phase:
|
Phase 1/Phase 2
|
|
Countries of recruitment
|
United States
| | | | | | | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Retinitis Pigmentosa
|
Intervention(s)
|
Drug: Lutein (10 or 30 mg/day) capsules
|
Secondary ID(s)
|
R21 AT000292-01
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|